Drugs / Salmeterol/Fluticasone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01202097 Comparator | Aug 2011 → May 2012 | asthma | Eurofarma Laboratorios S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Salmeterol/Fluticasone | “A PHASE III, RANDOMIZED, OPEN-LABEL, NON-INFERIORITY COMPARATIVE STUDY BETWEEN SERETIDE® 50/250 ΜG and SALMETEROL/FLUTICASONE SINGLE INHALATION CAPSULE 50/250 ΜG EUROFARMA in...” NCT01202097 ↗ |
| Route | Inhaled | “Salmeterol/Fluticasone SINGLE INHALATION CAPSULE” NCT01202097 ↗ |